Your browser doesn't support javascript.
loading
Early impact of COVID-19 outbreak on eye care: Insights from EUROCOVCAT group.
Toro, Mario Damiano; Brézin, Antoine Pierre; Burdon, Michael; Cummings, Arthur Bernard; Evren Kemer, Ozlem; Malyugin, Boris Edvard; Prieto, Isabel; Teus, Miguel Angel; Tognetto, Daniele; Törnblom, Riikka; Posarelli, Chiara; Choragiewicz, Tomasz; Rejdak, Robert.
Afiliación
  • Toro MD; Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.
  • Brézin AP; Faculty of Medicine, Collegium Medicum Cardinal Stefan Wyszynski University, Warsaw, Poland.
  • Burdon M; Université de Paris, Hôpital Cochin, Paris, France.
  • Cummings AB; Queen Elizabeth Hospital, Birmingham, UK.
  • Evren Kemer O; Wellington Eye Clinic, Dublin, Ireland.
  • Malyugin BE; University of Health Sciences, Ankara City Hospital, Turkey.
  • Prieto I; Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation.
  • Teus MA; Fernando Fonseca Hospital, Amadora, Portugal.
  • Tognetto D; University of Alcalá, Madrid, Spain.
  • Törnblom R; University Eye Clinic, Trieste, Italy.
  • Posarelli C; TYKS Hospital, Turku, Finland.
  • Choragiewicz T; Department of Surgical, Medical, Molecular Pathology and of the Critical Area, University of Pisa, Pisa, Italy.
  • Rejdak R; Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland.
Eur J Ophthalmol ; 31(1): 5-9, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32967466
The recent outbreak of coronavirus disease 2019 (COVID-19) has been declared a public health emergency worldwide. The scientific community has put in much effort and published studies that described COVID-19's biology, transmission, clinical diagnosis, candidate therapeutics, and vaccines. However, to date, only a few data are available on the impact of COVID-19 pandemic on ophthalmological care in different health care systems, its future consequences in terms of disability, and access to sight-saving cures for many patients. To reduce human-to-human transmission of the virus and also ensure supply of infrastructures, human resources, and disposable medical devices to many regions, it is crucial to assess risks and postpone non-essential outpatient visits and elective surgical procedures, especially in older patients and those with comorbidities. This delay or suspension in essential eye procedures may cause significant and rapid vision impairment to irreversible blindness. Determining the risk-benefit profile of treating these ocular pathologies is a public health issue of supreme priority, even though many patients benefiting from therapeutic treatments are elderly, who are more vulnerable to COVID-19. If not reversible, this process could lead to a dramatic increase in disability and unsustainable social costs for many Governments.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Brotes de Enfermedades / Transmisión de Enfermedad Infecciosa de Paciente a Profesional / Atención a la Salud / Oftalmopatías / SARS-CoV-2 / COVID-19 Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Eur J Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Brotes de Enfermedades / Transmisión de Enfermedad Infecciosa de Paciente a Profesional / Atención a la Salud / Oftalmopatías / SARS-CoV-2 / COVID-19 Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Eur J Ophthalmol Asunto de la revista: OFTALMOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos